Skip to content

Serum betatrophin levels and its influencing factors in patients with autoimmune thyroid disease

Serum betatrophin levels and its influencing factors in patients with autoimmune thyroid disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006745
Enrollment
Unknown
Registered
2015-07-13
Start date
2015-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune thyroid disease

Interventions

Patients with overt hypothyroidism (HT-OH) group:Measuring physical index and blood specimens
Patients with subclinical hypothyroidism group:Measuring physical index and blood specimens
Patients with euthyroidism group:Measuring physical index and blood specimens
Normal control:Measuring physical index and blood specimens

Sponsors

the First People's Hospital, Xuzhou, Jiangsu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patients with overt hypothyroidism (HT-OH), subclinical hypothyroidism (HT-SCH) and euthyroidism were selected from subjectswith newly diagnosed autoimmune thyroid disease. Age-, sex- and BMI-matched healthy person were assigned to the control group.

Exclusion criteria

Exclusion criteria: Patients who had a history of cardiovascular disease, diabetes mellitus or any systemic disease other than autoimmune thyroid disease were excluded.

Design outcomes

Primary

MeasureTime frame
Betatrophin;Thyroid function index;blood lipid profile;liver function index;hypersensitive c-reactive protein (hs-crp);nonalcoholic fatty liver disease;OGTT;insulin releasing test;BMI;Age;Sex;blood pressure;

Countries

China

Contacts

Public ContactWang Zhaoling
dyywzl@126.com+86 13852103069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026